BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

43 related articles for article (PubMed ID: 3729470)

  • 1. [Epidemiologic methods of estimation of a secondary cancer associated with cancer treatment].
    Tominaga S
    Gan To Kagaku Ryoho; 1986 Apr; 13(4 Pt 2):1528-33. PubMed ID: 3729470
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
    Piver MS
    Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A validation of estimating the national cancer incidence in Korea using the databases of 7 population-based regional cancer registries except Seoul].
    Community of Population-based Regional Cancer Registries in Korea
    J Prev Med Public Health; 2009 Mar; 42(2):130-4. PubMed ID: 19349743
    [TBL] [Abstract][Full Text] [Related]  

  • 4. "Just Another Statistic".
    Machtay M; Glatstein E
    Oncologist; 1998; 3(3):III-IV. PubMed ID: 10388105
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of long-term exposure to traffic-related air pollution on respiratory and cardiovascular mortality in the Netherlands: the NLCS-AIR study.
    Brunekreef B; Beelen R; Hoek G; Schouten L; Bausch-Goldbohm S; Fischer P; Armstrong B; Hughes E; Jerrett M; van den Brandt P
    Res Rep Health Eff Inst; 2009 Mar; (139):5-71; discussion 73-89. PubMed ID: 19554969
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [An estimation of the national cancer incidence in Korea for 2000-2002 using the databases of 8 population-based regional cancer registries].
    Community of Population-based Regional Cancer Registries in Korea
    J Prev Med Public Health; 2008 Nov; 41(6):380-6. PubMed ID: 19037167
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cancer incidence and mortality in France over the period 1978-2000.
    Remontet L; Estève J; Bouvier AM; Grosclaude P; Launoy G; Menegoz F; Exbrayat C; Tretare B; Carli PM; Guizard AV; Troussard X; Bercelli P; Colonna M; Halna JM; Hedelin G; Macé-Lesec'h J; Peng J; Buemi A; Velten M; Jougla E; Arveux P; Le Bodic L; Michel E; Sauvage M; Schvartz C; Faivre J
    Rev Epidemiol Sante Publique; 2003 Feb; 51(1 Pt 1):3-30. PubMed ID: 12684578
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiple cancer sites incidence rates estimation using a multivariate Bayesian model.
    Assunção RM; Castro MS
    Int J Epidemiol; 2004 Jun; 33(3):508-16. PubMed ID: 15044411
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NTP Toxicology and Carcinogenesis Studies of AZT (CAS No. 30516-87-1) and AZT/alpha-Interferon A/D B6C3F1 Mice (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1999 Feb; 469():1-361. PubMed ID: 12579204
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A mathematical estimation of true cancer incidence using data from population-based cancer registries.
    Kamo K; Kaneko S; Satoh K; Yanagihara H; Mizuno S; Sobue T
    Jpn J Clin Oncol; 2007 Feb; 37(2):150-5. PubMed ID: 17272318
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Estimation of the future epidemiological situation of tuberculosis in Japan].
    Ohmori M; Yoshiyama T; Ishikawa N
    Kekkaku; 2008 Apr; 83(4):365-77. PubMed ID: 18516900
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incidence of skin cancers in 3867 patients treated with narrow-band ultraviolet B phototherapy.
    Hearn RM; Kerr AC; Rahim KF; Ferguson J; Dawe RS
    Br J Dermatol; 2008 Sep; 159(4):931-5. PubMed ID: 18834483
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adjustment of cancer incidence rates for ethnic misclassification.
    Stewart SL; Swallen KC; Glaser SL; Horn-Ross PL; West DW
    Biometrics; 1998 Jun; 54(2):774-81. PubMed ID: 9629656
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NTP Toxicology and Carcinogenesis Studies of Triethanolamine (CAS No. 102-71-6) in F344 Rats and B6C3F1 Mice (Dermal Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1999 Nov; 449():1-298. PubMed ID: 12594526
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cancer trends in Sweden until 2010.
    Acta Oncol; 1996; 35 Suppl 6():37-45. PubMed ID: 9154084
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence of cancer in a cohort of patients with primary Sjogren's syndrome.
    Lazarus MN; Robinson D; Mak V; Møller H; Isenberg DA
    Rheumatology (Oxford); 2006 Aug; 45(8):1012-5. PubMed ID: 16490754
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety and efficacy of the specific endothelin-A receptor antagonist ZD4054 in patients with hormone-resistant prostate cancer and bone metastases who were pain free or mildly symptomatic: a double-blind, placebo-controlled, randomised, phase 2 trial.
    James ND; Caty A; Borre M; Zonnenberg BA; Beuzeboc P; Morris T; Phung D; Dawson NA
    Eur Urol; 2009 May; 55(5):1112-23. PubMed ID: 19042080
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [What rate of cure for cancer?].
    Hill C
    Bull Cancer; 1998 Sep; 85(9):745-6. PubMed ID: 9817057
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NTP Toxicology and Carcinogenesis Studies of 3,4-Dihydrocoumarin (CAS No. 119-84-6) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1993 Sep; 423():1-336. PubMed ID: 12616288
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An international cohort study of cancer in systemic lupus erythematosus.
    Bernatsky S; Boivin JF; Joseph L; Rajan R; Zoma A; Manzi S; Ginzler E; Urowitz M; Gladman D; Fortin PR; Petri M; Edworthy S; Barr S; Gordon C; Bae SC; Sibley J; Isenberg D; Rahman A; Aranow C; Dooley MA; Steinsson K; Nived O; Sturfelt G; Alarcón G; Senécal JL; Zummer M; Hanly J; Ensworth S; Pope J; El-Gabalawy H; McCarthy T; St Pierre Y; Ramsey-Goldman R; Clarke A
    Arthritis Rheum; 2005 May; 52(5):1481-90. PubMed ID: 15880596
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.